TYME Technologies, Inc. Reports Fourth Fiscal Quarter and Full Year 2022 Financial and Operating Results
25.05.2022 - - $84.0 million in cash and marketable securities as of March 31, 2022 -BEDMINSTER, N.J., May 25, 2022 (GLOBE NEWSWIRE) - TYME Technologies, Inc. (Nasdaq: TYME) (the Company or TYME), an emerging biotechnology company developing cancer ...